Title: Pharmaceutical R&D in an era of managed healthcare: using integrative teams to produce enduring competitive advantage

Authors: Theresa K. Lant, Alan B. Eisner

Addresses: Management Department, The Stern School of Business, New York University, 44 W. 4th Street, New York, NY 10012, USA. Management and Management Science Department, Lubin School of Business, Pace University, 861 Bedford Road, Pleasantville, NY 10570, USA

Abstract: Medical technology organisations are faced with greater performance pressure in the new managed healthcare environment. In particular, pharmaceutical research and development (R&D) organisations are expected to create new and useful therapeutic treatments with greater resource constraints than ever previously experienced. We explore how pharmaceutical R&D organisations are changing the way they manage the research process in response to changing organisational and environmental constraints. This paper suggests an integrative team approach to the efficient and effective management of pharmaceutical R&D in a managed healthcare environment. We view integrative teams as an important means of increasing R&D productivity and producing competitive advantage.

Keywords: pharmaceutical research and development; managed healthcare; teams; capabilities; competence.

DOI: 10.1504/IJTM.1998.002616

International Journal of Technology Management, 1998 Vol.15 No.3/4/5, pp.299-321

Published online: 29 Jul 2003 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article